AGAnezka Gryndlerova

Anezka Gryndlerova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anezka Gryndlerova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Betigül Öngen

    Medical Microbiology Department, İstanbul Faculty of Medicine, İstanbul University, 34093 İstanbul, Türkiye

    1 shared publication
  • Coralie Bouchiat

    Laboratoire de Bactériologie, Institut des Agents Infectieux, Biologie Moléculaire, Hospices Civils de Lyon, Lyon, France

    1 shared publication
  • Gabriele Bianco

    Department of Experimental Medicine, University of Salento, Lecce, Italy

    1 shared publication
  • Kristian Schønning

    Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

    1 shared publication
  • Libor Fila

    Department of Pneumology, Second Faculty of Medicine, Charles University, and Motol and Homolka University Hospital, Prague, Czech Republic

    1 shared publication
  • Marcela Krutova

    Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol and Homolka University Hospital, Prague, Czech Republic

    1 shared publication

Latest Publications

  • Open Access

    Does macrolide resistance play a role in the clinical outcome of patients with Mycoplasma pneumoniae infection?

    by Marek Stefan, Renata Sindlerova, Barbora Dratvova, Libor Fila, Zdenek Sumnik, Pavel Drevinek, Milan Trojanek, Marcela Krutova

  • Nonfermenting Gram-Negative Bacilli Other Than Pseudomonas and Acinetobacter Species in Pediatric Blood Cultures: A Multicenter European Analysis

    by Gabriele Bianco, Anezka Gryndlerova, Kristian Schønning, Stefanie van Kleef - van Koeveringe, Stéphane Corvec, Coralie Bouchiat, Vincent Jean-Pierre, Betigül Öngen, Rafael Cantón, Matteo Boattini

    Background: Nonfermenting Gram-negative bacilli other than Pseudomonas and Acinetobacter species are increasingly recognized as opportunistic pathogens in pediatric populations, yet their epidemiology and antimicrobial resistance remain poorly defined. Methods: We conducted a multicenter retrospective analysis across 56 hospital centers in 25 European countries, including pediatric blood culture isolates collected between January 2020 and December 2024. Species distribution and antimicrobial susceptibility profiles according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) current guidelines were analyzed. Results: A total of 382 isolates were included, spanning 19 genera and 40 species. Stenotrophomonas maltophilia was the most frequently identified species (46.9%; n = 179), followed by Roseomonas mucosa (10%; n = 38) and Sphingomonas paucimobilis (7.6%; n = 29). Susceptibility profiles were heterogeneous, with notable resistance across several species. For S. maltophilia , resistance to trimethoprim/sulfamethoxazole exceeded 10% (EUCAST), while full in vitro susceptibility to aztreonam/avibactam was observed. Preserved activity of carbapenems but high resistance to ceftazidime (EUCAST/CLSI), piperacillin/tazobactam (EUCAST/CLSI) and ciprofloxacin (CLSI) was observed for S. paucimobilis . Achromobacter several species showed concerning resistance patterns to carbapenems, piperacillin/tazobactam and trimethoprim/sulfamethoxazole (CLSI). Conclusions: Nonfermenting Gram-negative bacilli other than Pseudomonas and Acinetobacter species were frequently associated with healthcare exposure and complex resistance profiles. Their management is challenged by a lack of evidence and standardized susceptibility criteria. To optimize management, enhanced surveillance, improved diagnostic standardization and further clinical studies on emerging therapies are needed.